logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Hydroxychloroquine/lopinavir/ritonavirLack of efficacy following off-label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2022年 / 1908卷 / 1期
关键词:
D O I:
10.1007/s40278-022-16003-8
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:275 / 275
相关论文
共 50 条
  • [41] LorazepamLack of efficacy following off-label use: case report
    Reactions Weekly, 2022, 1919 (1) : 354 - 354
  • [42] AzithromycinLack of efficacy following an off-label use: case report
    Reactions Weekly, 2022, 1915 (1) : 92 - 92
  • [43] RuxolitinibLack of efficacy following off-label use: case report
    Reactions Weekly, 2024, 2039 (1) : 502 - 502
  • [44] EribulinLack of efficacy following off-label use: case report
    Reactions Weekly, 2022, 1921 (1) : 135 - 135
  • [45] ImiquimodLack of efficacy following off-label use: case report
    Reactions Weekly, 2022, 1920 (1) : 254 - 254
  • [46] IbrutinibLack of efficacy following off-label use: case report
    Reactions Weekly, 2025, 2042 (1) : 209 - 209
  • [47] InterferonLack of efficacy following off-label use: case report
    Reactions Weekly, 2024, 2025 (1) : 231 - 231
  • [48] VedolizumabLack of efficacy following off-label use: case report
    Reactions Weekly, 2023, 1938 (1) : 1250 - 1250
  • [49] TocilizumabLack of efficacy following off-label use: case report
    Reactions Weekly, 2022, 1887 (1) : 643 - 643
  • [50] DexamethasoneLack of efficacy following off-label use: case report
    Reactions Weekly, 2022, 1936 (1) : 195 - 195
← 12345 →